The FDA has approved Sanofi’s Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) to improve glycemic control in adults and pediatric patients with diabetes. Merilog is a ...

New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control in adults ...

The federal agency has approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.

When you buy something using these coupons, we may earn a small affiliate commission. TIME is involved in the coupon selection process, working closely with Savings United to bring you the best ...